Knowing the new Omicron BA.2.75 variant ('Centaurus'): A simulation study

Affiliations

¹ Department of Medicine and Surgery, Department of Medicine and Cardiopulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, University of Insubria, Via Crotto Roncaccio 16, Tradate, VA, Italy.
² Fondazione Umbra Cuore e Ipertensione-ONLUS and Division of Cardiology, Hospital S. Maria della Misericordia, Perugia, Italy.
³ Department of Medicine and Surgery, Department of Medicine and Cardiopulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, University of Insubria, Via Crotto Roncaccio 16, Tradate, VA, Italy; Istituti Clinici Scientifici Maugeri, IRCCS Tradate, Italy. Electronic address: angeli.internet@gmail.com.

Comment

Martina Zappa et al. Eur J Intern Med. 2022 Nov.

. 2022 Nov:105:107-108.

doi: 10.1016/j.ejim.2022.08.009. Epub 2022 Aug 15.

¹ Department of Medicine and Surgery, Department of Medicine and Cardiopulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, University of Insubria, Via Crotto Roncaccio 16, Tradate, VA, Italy.
² Fondazione Umbra Cuore e Ipertensione-ONLUS and Division of Cardiology, Hospital S. Maria della Misericordia, Perugia, Italy.
³ Department of Medicine and Surgery, Department of Medicine and Cardiopulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, University of Insubria, Via Crotto Roncaccio 16, Tradate, VA, Italy; Istituti Clinici Scientifici Maugeri, IRCCS Tradate, Italy. Electronic address: angeli.internet@gmail.com.

No abstract available

Conflict of interest statement

Declaration of Competing Interest None of the authors of this study has financial or other reasons that could lead to a conflict of interest.

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.
Kliker L, Zuckerman N, Atari N, Barda N, Gilboa M, Nemet I, Abd Elkader B, Fratty IS, Jaber H, Mendelson E, Alroy-Preis S, Kreiss Y, Regev-Yochay G, Mandelboim M. Kliker L, et al. Euro Surveill. 2022 Jul;27(30):2200559. doi: 10.2807/1560-7917.ES.2022.27.30.2200559. Euro Surveill. 2022. PMID: 35904058 Free PMC article.

1. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–590. - PMC - PubMed
1. Ramos SG, Rattis B, Ottaviani G, Celes MRN, Dias EP. ACE2 Down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients. Am J Pathol. 2021;191:1154–1164. - PMC - PubMed
1. Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14–20. - PMC - PubMed
1. Angeli F, Reboldi G, Trapasso M, Zappa M, Spanevello A, Verdecchia P. COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect". Eur J Intern Med. 2022 - PMC - PubMed
1. Angeli F, Zappa M, Oliva FM, Spanevello A, Verdecchia P. Blood pressure increase during hospitalization for COVID-19. Eur J Intern Med. 2022 - PMC - PubMed